These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 38733262)

  • 1. Comparison of Interstitial Lung Disease Between Antineutrophil Cytoplasmic Antibodies Positive and Negative Patients: A Retrospective Cohort Study.
    Shen HC; Bui KA; Richard R; Toban N; Lévesque M; Meunier RS; Ross C; Makhzoum JP
    ACR Open Rheumatol; 2024 Aug; 6(8):463-469. PubMed ID: 38733262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence and Patterns of Interstitial Lung Disease and Their Clinical Impact on Mortality in Patients with Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: Korean Single-Centre Observational Study.
    Ha JW; Pyo JY; Ahn SS; Song JJ; Park YB; Lee SW
    J Immunol Res; 2022; 2022():2499404. PubMed ID: 35655922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interstitial Lung Disease in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis Patients: Comparison With Idiopathic Pulmonary Fibrosis.
    Kwon M; Lee AS; Mira-Avendano I; Rojas CA; Grage R; Abril A
    J Clin Rheumatol; 2021 Dec; 27(8):324-330. PubMed ID: 32251058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical significance of acute exacerbation in interstitial lung disease with antineutrophil cytoplasmic antibody: an indicator of poor prognosis.
    Wu T; Zhang Y; Cen Z; Ying Y; Sun C; Lv C; Ding Q
    Ther Adv Respir Dis; 2022; 16():17534666221140974. PubMed ID: 36484348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Usual interstitial pneumonia in ANCA-associated vasculitis: A poor prognostic factor.
    Maillet T; Goletto T; Beltramo G; Dupuy H; Jouneau S; Borie R; Crestani B; Cottin V; Blockmans D; Lazaro E; Naccache JM; Pugnet G; Nunes H; de Menthon M; Devilliers H; Bonniaud P; Puéchal X; Mouthon L; Bonnotte B; Guillevin L; Terrier B; Samson M;
    J Autoimmun; 2020 Jan; 106():102338. PubMed ID: 31570253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interstitial lung disease in ANCA-associated vasculitis: associated factors, radiographic features and mortality.
    Doliner B; Rodriguez K; Montesi SB; Fu X; Sharma A; Wallace ZS
    Rheumatology (Oxford); 2023 Feb; 62(2):716-725. PubMed ID: 35699465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiologic and pathologic characteristics of myeloperoxidase-antineutrophil cytoplasmic antibody-associated interstitial lung disease: a retrospective analysis.
    Baqir M; Yi EE; Colby TV; Cox CW; Ryu JH; Specks U
    Sarcoidosis Vasc Diffuse Lung Dis; 2019; 36(3):195-201. PubMed ID: 32476954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interstitial lung disease in microscopic polyangiitis and granulomatosis with polyangiitis: demographic, clinical, serological and radiological features of an Italian cohort from the Italian Society for Rheumatology.
    Manfredi A; Cassone G; Izzo R; Dallagiacoma G; Felicetti M; Cariddi A; Berti A; Giollo A; Nannini C; Bettio S; Monti S; Conticini E; Govoni M; Quartuccio L; Argolini LM; Kaleci S; Emmi G; Dejaco C; Padoan R; Dagna L; Rossini M; Cantini F; Montecucco C; Frediani B; De Vita S; Caporali R; Muratore F; Sebastiani M; Salvarani C;
    Clin Exp Rheumatol; 2023 Apr; 41(4):821-828. PubMed ID: 36200955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical differences among patients with myeloperoxidase-antineutrophil cytoplasmic antibody-positive interstitial lung disease.
    Yamaguchi K; Yamaguchi A; Ito M; Wakamatsu I; Itai M; Muto S; Uno S; Aikawa M; Kouno S; Takemura M; Yatomi M; Aoki-Saito H; Koga Y; Hara K; Motegi S; Tsukida M; Ota F; Tsukada Y; Motegi M; Nakasatomi M; Sakairi T; Ikeuchi H; Kaneko Y; Hiromura K; Maeno T
    Clin Rheumatol; 2023 Feb; 42(2):479-488. PubMed ID: 36194347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patterns of Interstitial Lung Disease and Prognosis in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
    Zhou P; Li Z; Gao L; Zhao B; Que C; Li H; Ma J; Wang G
    Respiration; 2023; 102(4):257-273. PubMed ID: 36693330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antineutrophil cytoplasmic antibody-associated interstitial lung disease: a review.
    Kadura S; Raghu G
    Eur Respir Rev; 2021 Dec; 30(162):. PubMed ID: 34750115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-Citrullinated Peptide Antibody Expression and Its Association with Clinical Features and Outcomes in Patients with Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
    Ahn SS; Pyo JY; Song JJ; Park YB; Lee SW
    Medicina (Kaunas); 2022 Apr; 58(4):. PubMed ID: 35454396
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical impact of antineutrophil cytoplasmic antibody positivity on the occurrence of interstitial lung disease in patients with polymyositis/dermatomyositis.
    Ha JW; Pyo JY; Ahn SS; Song JJ; Park YB; Lee SW
    Ann Palliat Med; 2022 Oct; 11(10):3181-3192. PubMed ID: 36226644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utility of anti-neutrophil cytoplasmic antibody screening in idiopathic interstitial lung disease.
    Fidler LM; Kandel S; Fisher JH; Mittoo S; Shapera S
    Sarcoidosis Vasc Diffuse Lung Dis; 2021; 38(2):e2021015. PubMed ID: 34316255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Indications and diagnostic outcome of antineutrophil cytoplasmic antibody testing in hospital medicine: a pattern of over-screening.
    Xu Y; Khamis N; Khosravi-Hafshejani T; Tan J; Miles E; Avina-Zubieta JA; Shojania K; Nimmo M; Dehghan N
    Clin Rheumatol; 2021 Dec; 40(12):4983-4991. PubMed ID: 34342740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antineutrophil cytoplasmic antibody is an independent risk factor in rheumatoid arthritis-associated interstitial lung disease.
    Xu H; Wu Z; Zhao Y; Hu C; Li P; Deng C; Li L; Bai Y; Song N; Luo J; Feng F; He C; Li Y; Zhang S
    Clin Chim Acta; 2024 Jul; 561():119845. PubMed ID: 38969087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The clinical features and prognosis of interstitial lung disease patients with positive anti-neutrophil cytoplasmic antibody].
    Gao C; Sun X; Huang J; Peng M; Sun XF; Zhang T; Shi JH
    Zhonghua Jie He He Hu Xi Za Zhi; 2020 Apr; 43(4):362-368. PubMed ID: 32294819
    [No Abstract]   [Full Text] [Related]  

  • 18. Interstitial Lung Disease in ANCA-Associated Vasculitis: Pathogenic Considerations and Impact for Patients' Outcomes.
    Sun K; Fisher JH; Pagnoux C
    Curr Rheumatol Rep; 2022 Aug; 24(8):259-267. PubMed ID: 35794350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute exacerbation in antineutrophil cytoplasmic antibody-associated interstitial lung disease: Clinical features and risk factors.
    Otsuka J; Yoshizawa S; Ikematsu Y; Kudo K; Osoreda H; Ishimatsu A; Taguchi K; Moriwaki A; Wakamatsu K; Iwanaga T; Yoshida M
    Respir Med; 2022 Nov; 203():106992. PubMed ID: 36252462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of TERT and DSP variants with microscopic polyangiitis and myeloperoxidase-ANCA positive vasculitis in a Japanese population: a genetic association study.
    Kawasaki A; Namba N; Sada KE; Hirano F; Kobayashi S; Nagasaka K; Sugihara T; Ono N; Fujimoto T; Kusaoi M; Tamura N; Yamagata K; Sumida T; Hashimoto H; Ozaki S; Makino H; Arimura Y; Harigai M; Tsuchiya N
    Arthritis Res Ther; 2020 Oct; 22(1):246. PubMed ID: 33076992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.